Thomas Van Cann
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research.
Journal: Sarcoma
Published: December 01, 2020
Retrospective Analysis of Patients with Advanced Liposarcoma in a Tertiary Referral Center.
Journal: Oncology research and treatment
Published: January 01, 2019
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 10, 2018
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
Journal: The Lancet. Respiratory medicine
Published: January 17, 2018
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 08, 2017
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 27, 2017
Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab.
Journal: Acta clinica Belgica
Published: July 12, 2017
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 09, 2017
Single-Center Experience with Intimal Sarcoma, an Ultra-Orphan, Commonly Fatal Mesenchymal Malignancy.
Journal: Oncology research and treatment
Published: November 03, 2016
Biology and management of clear cell sarcoma: state of the art and future perspectives.
Journal: Expert review of anticancer therapy
Published: June 03, 2016
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases.
Journal: British journal of cancer
Published: November 08, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026